Clinical Trial

A Prospective, Open-label, Pivotal Study to Assess Spectacle Hearing Aid Safety and Efficacy

Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
Following informed consent signature and upon verification of eligibility and execution of informed consent, subjects will be assigned a study code. The study comprises two groups. Screening visit will be conducted for both groups and include hearing test battery to assess hearing aid safety and efficacy
Trial Details
NCT Number NCT07282028
Lead Sponsor Nuance Hearing
Collaborators: Assuta Medical Center
Conditions Hearing Loss Mixed
Enrollment 89 participants
Start Date 2025-07-27
Primary Completion 2026-11 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-12-15